Topic: How To Invest

Power Growth Investor Hotline – Friday, January 10, 2025

Article Excerpt

BOSTON SCIENTIFIC CORP., $94.88, is a buy. The company (symbol BSX on New York) develops and markets medical devices used in minimally invasive procedures. Its products are used for angioplasty (blood vessel repair), blood clot filtration, cardiac rhythm management, catheter-aided ultrasound imaging, and many other surgical procedures. It generates 60% of its sales in the U.S. and 40% internationally. The company has now agreed to acquire the rest of Bolt Medical, the developer of an intravascular-lithotripsy, or IVL, laser-based platform for the treatment of coronary and peripheral artery disease. Boston Scientific already owns 26% of Bolt. The purchase price is $443 million. The deal also includes payments of up to $221 million upon the achievement of certain regulatory milestones. Bolt’s platform is instrumental in treating coronary and peripheral artery disease by fracturing calcium deposits to restore blood flow. Boston Scientific initially developed the concept for the Bolt IVL system, which is engineered to fracture calcium using acoustic pressure waves within a balloon catheter. Bolt…